Abstract
Brucellosis has been described rarely in patients infected with HIV, despite the fact that eradication of intracellular brucellae is largely dependent on cell-mediated immunity. The characteristics of all patients with HIV infection and brucellosis seen in seven Spanish hospitals are reported. Since the beginning of the AIDS epidemic, 12 HIV-infected patients were diagnosed with brucellosis (8 with cultures positive forBrucella spp., 4 with high anti-Brucella antibody titers). Most patients were male and intravenous drug users. Eleven patients had no symptoms of HIV infection when first diagnosed with brucellosis and had relatively preserved cellular immunity (median CD4+ cell count 588, range 136–1006). There was a clear epidemiologic antecedent for acquisition of brucellosis in 11 patients. Clinical symptoms included fever, arthromyalgia, and sweating in all patients; four patients presented with focal disease. All patients had high agglutinin titers, and eight of nine had cultures positive forBrucella. Therapy with doxycycline and streptomycin was curative in all cases. Two patients experienced a recurrence of symptoms after initial treatment, although no microbiological relapses were documented after a median follow-up period of 18 months. HIV infection does not seem to increase the incidence of brucellosis. Since most cases occur in asymptomatic patients with relatively preserved immunity, the epidemiology, clinical presentation, diagnosis, response to therapy, and outcome are similar to those observed in non-HIV infected patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ariza J: Brucelosis, algunos aspectos de su epidemiologia. Enfermedades Infecciosas y Microbiologia Clínica (1989) 7:517–518
Buchanan TM, Hendricka S, Paton CH, Feldman RA: Brucellosis in the United States, 1960–1972. An abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (1974) 53:427–438
Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, Fenech FF: Human brucellosis in Kuwait: a prospective study of 400 cases. Quarterly Journal of Medicine (1988) 66:39–54
Mousa ARM, Elhag KM, Khogali M, Marafie AA: The nature of human brucellosis in Kuwait: study of 379 cases. Reviews of Infectious Diseases (1988) 10:211–217
Spink WW: The nature of brucellosis. University of Minnesota Press, Minneapolis, 1956, pp. 145–190
Wise RI: Brucellosis in the United States. Past, present and future. Journal of the American Medical Association (1980) 244:2318–2322
Young EJ: An overview of human brucellosis. Clinical Infectious Diseases (1995) 21:283–290
Oksenhendler E, Morinière B, Rouveix E: Brucellosis in hairy cell leukaemia. Transactions of the Royal Society of Tropical Medicine and Hygiene (1988) 82:336
Raziuddin S, Bilal N, Benjamin B: Transient T-cell abnormality in a selective IgM-immunodeficient patient withBrucella infection. Clinical Immunology and Immunopathology (1988) 46:360–367
Martín I, Ramos C, Gutiérrez A, Arazo P, Aguirre JM: Infección por VIH y brucelosis crónica. Enfermedades Infecciosas y Microbiologia Clínica (1992) 10:566–567
Pedro-Botet J, Coll J, Auguet T, Rubiés-Prat J: Brucellosis and HIV infection: a casual association? AIDS (1992) 6:1039–1040
Rubio A, Portu J, Zubizarreta J, Ayensa C: Meningitis porBrucella abortus en un paciente con infección por el virus de la immunodeficiencia humana. Medicina Clinica (Barcelona) (1992) 99:678
Valladares M, Viciana P, Martín A, del Nozal M: Brucelosis aguda e infección por VIH: una nueva particularidad. Enfermedades Infecciosas y Microbiologia Clínica (1993) 11:511–512
Ministerio de Sanidad y Consumo, Dirección General de Salud PÚblica: Comentario epidemiológico de las enfermedades de declaración obligatoria national. Año 1988. Boletin Epidemiológico Semanal (1989), No. 1825
Ministerio de Sanidad y Consumo: Epidemiologia del SIDA en España. DIN Impresores, Madrid, December (1995):7–90
Alton GG, Jones LM, Pietz DE: Laboratory techniques in brucellosis. World Health Organization Monograph No. 55 (1975), p. 11–67
Jones LM, Wundt W: International Committee on Nomenclature of Bacteria. Subcommittee on the Taxonomy ofBrucella. Minutes of meeting. International Journal of Systematic Bacteriology (1971) 21:126–128
Morgan WP, Mackinnon DJ, Lawson JR, Cullen GA: The rose Bengal plate agglutination test in the diagnosis of brucellosis. Veterinaire Recherche (1969) 85:636–641
Ruiz-Castañeda M: Laboratory diagnosis of brucellosis in man. Bulletin of the World Health Organization (1961) 24:73–84
Colmenero JD, Reguera JM, Martos F, Sánchez de Mora D, Delgado M, Causse M: Complications associated withBrucella melitensis infection: Study of 530 cases. Medicine (1996) 75:195–211
Sulitzeanu D: Mechanisms of immunity againstBrucella. Nature (1965) 205:1086–1088
Pantaleo G, Graziosi C, Fauci AS: New concepts in the immunopathogenesis of human immunodeficiency virus infection. New England Journal of Medicine (1993) 328:327–335
Grupo de Trabajo para el Estudio de Infecciones en Drogadictos: Estudio multicéntrico de las complicaciones infecciosas en adictos a drogas por vía parenteral en España: análisis final de 17.592 casos (1977–1991). Enfermedades Infecciosas y Microbiologia Clinica (1995) 13:532–539
Giasuddin ASM, Ziu MM, Shaafie IA: Brucella and HIV-1 antibodies in Libyan blood donors. Journal of Infection (1991) 22:294–296
Paul J, Gilks C, Batchelor B, Ojoo J, Amir M, Selkon JB: Serological response to brucellosis in HIV-seropositive patients. Transactions of the Royal Society of Tropical Medicine and Hygiene (1995) 89:228–230
Buchanan TM, Hendricka S, Paton CH, Feldman RA: Brucellosis in the United States, 1960–1972. An abbattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine (1974) 53:427–438
Ariza J, Pujol M, Valverde J, Nolla JM, Rufí G, Fernández-Viladrich P: Brucellar sacroiliitis: findings in 63 episodes and current relevance. Clinical Infectious Diseases (1993) 16:761–765
Mousa ARM, Muhtaseb SA, Almudallal DS, Khodeir SM, Marafie AA: Osteoarticular complication of brucellosis: a study of 169 cases. Reviews of Infectious Diseases (1987) 9:531–543
Galle C, Struelens M, Liesnard C, Godfraid J, Yaes N, Dewitte O, Farber CM, Clevenberg P, Van Vooren JP:Brucella melitensis osteitis following craniotomy in a patient with AIDS. Clinical Infectious Diseases 1997, 24:1012
Acocella G, Bertrand A, Beytout J, Durrande JB, García-Rodríguez JA, Kosmidis J: Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. Journal of Antimicrobial Chemotherapy (1989) 23:433–439
Ariza J, Gudiol F, Pallarés R, Fernández-Viladrich P, Rufí G, Corredoira J: Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Annals of Internal Medicine (1992) 117:25–30
Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P: Comparative trial of rifampin-doxycycline versus tetracyclinestreptomycin in the therapy of human brucellosis. Antimicrobial Agents and Chemotherapy (1985) 28:548–551
Cisneros JM, Viciana P, Colmenero J, Pachón J, Martínez C, Alarcón A: Multicenter prospective study of treatment ofBrucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Antimicrobial Agents and Chemotherapy (1990) 34:881–883
Colmenero JD, Hernández S, Reguera JM, Cabrera F, Rius F, Alonso A: Comparative trial of doxycycline plus streptomycin versus dosycycline plus rifampin for the therapy of human brucellosis. Chemotherapy (1989) 35:146–152
Solera J, Medrano F, Rodríguez M, Geijo P, Paulino J: Ensayo terapéutico comparativo y multicéntrico de rifampicina y doxiciclina frente a estreptomicina y doxiciclina en la brucelosis humana. Medicina Clinica (1991) 96:649–653
Solera J, Rodríguez Zapata M, Geijo P, Largo J, Paulino J, Saez L: Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due toBrucella melitensis. Antimicrobial Agents and Chemotherapy (1995) 39:2061–2067
Food and Agriculture Organization-World Health Organization: FAO-WHO Expert Committee on Brucellosis (6th report). WHO Technical Report Series (1986) 740:56–57
Burgaleta C: Actividad funcional de las células fagocíticas en la brucelosis. In: Baquero F, Buzón L (eds): Proceedings of an international symposium on brucellosis. Garsi, Madrid (1985), p. 43–49
Gazapo E, González Lahoz J, Subiza JL, Baquero M, Figueredo MA, Gómez de la Concha E: Subpoblaciones linfocitarias en la evolución de la brucelosis. Revista Clinica Española (1990) 186:369–373
Renoux M, Renoux G: Brucellosis immunodepression and levamisole. Lancet (1977) i:372
Riglar C, Cheers CH: Macrophage activation during experimental murine brucellosis. Inhibition of in vitro lymphocyte proliferation byBrucella activated macrophages. Cell Immunology (1980) 49:168–177
Rodríguez-Zapata M, Alvarez Mon M, Salmerón I, Prieto A, Manzano L, Salmerón OJ: Diminished T lymphocyte proliferative response to polyclonal mitogens in acute brucellosis patients. Infection (1996) 24:115–119
Rodríguez Zapata M, Salmerón I, Manzano L, Salmerón OJ, Prieto A, Alvarez Mon M: Defective Interferon gamma production by T lymphocytes from acute brucellosis patients. European Journal of Clinical Investigation (1996) 26:136–140
Salmerón I, Rodríguez Zapata M, Salmerón O, Manzano L, Vaquer S, Alvarez Mon M: Impaired activity of natural killer cells in patients with acute brucellosis. Clinical Infectious Diseases (1992) 15:764–770
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moreno, S., Ariza, J., Espinosa, F.J. et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 17, 319–326 (1998). https://doi.org/10.1007/BF01709454
Issue Date:
DOI: https://doi.org/10.1007/BF01709454